Journal of Immunotherapy
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherLIPPINCOTT WILLIAMS & WILKINS
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1991
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 13% |
| 4-6 | 42% |
| 7-9 | 27% |
| >9 | 18% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Journal of Immunotherapy been publishing? 
The Journal of Immunotherapy has been publishing since 1991 till date.
How frequently is the Journal of Immunotherapy published?
Journal of Immunotherapy is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Journal of Immunotherapy?
Journal of Immunotherapy has a H-index score of 103, Citescore of 7.9, SNIP score of 0.8, & SJR of Q1
Who is the publisher of Journal of Immunotherapy?
The publisher of Journal of Immunotherapy is LIPPINCOTT WILLIAMS & WILKINS.
How can I view the journal metrics of Journal of Immunotherapy on editage?
For the Journal of Immunotherapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Journal of Immunotherapy?
The eISSN number is 1537-4513 and pISSN number is 1524-9557 for Journal of Immunotherapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Immune checkpoint inhibitors, Odds ratio, Confidence interval, Pembrolizumab, Nivolumab, Autologous tumor, Melanoma, Tumor-infiltrating lymphocytes, Overall survival, Advanced melanoma, Colorectal cancer, Hazard ratio, Ipilimumab, Avelumab, Soft tissue sarcoma, Clinical trial, Attributable risk, Immunotherapy.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.